GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C-Mer Eye Care Holdings Ltd (HKSE:03309) » Definitions » EV-to-EBIT

C-Mer Eye Care Holdings (HKSE:03309) EV-to-EBIT : 25.26 (As of May. 06, 2024)


View and export this data going back to 2018. Start your Free Trial

What is C-Mer Eye Care Holdings EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, C-Mer Eye Care Holdings's Enterprise Value is HK$3,597 Mil. C-Mer Eye Care Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$142 Mil. Therefore, C-Mer Eye Care Holdings's EV-to-EBIT for today is 25.26.

The historical rank and industry rank for C-Mer Eye Care Holdings's EV-to-EBIT or its related term are showing as below:

HKSE:03309' s EV-to-EBIT Range Over the Past 10 Years
Min: 21.98   Med: 122.11   Max: 934.7
Current: 25.26

During the past 10 years, the highest EV-to-EBIT of C-Mer Eye Care Holdings was 934.70. The lowest was 21.98. And the median was 122.11.

HKSE:03309's EV-to-EBIT is ranked worse than
66.51% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 18.53 vs HKSE:03309: 25.26

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. C-Mer Eye Care Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was HK$4,272 Mil. C-Mer Eye Care Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$142 Mil. C-Mer Eye Care Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 3.33%.


C-Mer Eye Care Holdings EV-to-EBIT Historical Data

The historical data trend for C-Mer Eye Care Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Mer Eye Care Holdings EV-to-EBIT Chart

C-Mer Eye Care Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 80.79 488.43 199.68 718.61 30.00

C-Mer Eye Care Holdings Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 199.68 - 718.61 - 30.00

Competitive Comparison of C-Mer Eye Care Holdings's EV-to-EBIT

For the Medical Care Facilities subindustry, C-Mer Eye Care Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C-Mer Eye Care Holdings's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, C-Mer Eye Care Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where C-Mer Eye Care Holdings's EV-to-EBIT falls into.



C-Mer Eye Care Holdings EV-to-EBIT Calculation

C-Mer Eye Care Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=3597.366/142.391
=25.26

C-Mer Eye Care Holdings's current Enterprise Value is HK$3,597 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. C-Mer Eye Care Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$142 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C-Mer Eye Care Holdings  (HKSE:03309) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

C-Mer Eye Care Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=142.391/4272.1704
=3.33 %

C-Mer Eye Care Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was HK$4,272 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. C-Mer Eye Care Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$142 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C-Mer Eye Care Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of C-Mer Eye Care Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


C-Mer Eye Care Holdings (HKSE:03309) Business Description

Traded in Other Exchanges
N/A
Address
1-3 Pedder Street, Suite 1335, Central Building, Central, Hong Kong, HKG
C-Mer Eye Care Holdings Ltd provides general medical and surgical hospital services. It provides ophthalmic health care, diagnosis, treatment, surgical treatment services, and the sale of vision aid and pharmaceutical products in Hong Kong and the People's Republic of China. The company offers cataract, cornea, and ocular surface diseases, glaucoma, vitreoretinal and macular diseases, other eye diseases diagnosis and treatment services, and Chinese medicine treatment of eye diseases. Its segments include Sales of medical consumables, Mainland China ophthalmic business and Mainland China dental business. It generates a vast majority of its revenue from the provision of the ophthalmic services segment.

C-Mer Eye Care Holdings (HKSE:03309) Headlines

No Headlines